非洲慢阻肺的风险因素、住院、再入院及相关结局:系统综述与荟萃分析
该研究系统检索截至2021年10月1日的文献,纳入39项研究、其中13项进入荟萃分析,评估非洲慢阻肺患病率、风险因素、住院与再入院。荟萃分析显示既往结核、吸烟和生物质燃料使用是显著风险因素;长期氧疗和每年≥3次频繁住院与30天再入院相关。
要点
- 既往结核、吸烟、生物质燃料使用是非洲慢阻肺的显著风险因素。
- 长期氧疗与每年≥3次频繁住院是30天慢阻肺再入院的风险因素。
- 非洲多国缺乏慢阻肺研究,证据仍有限。
核心结论
- 研究突出非洲慢阻肺的特定风险因素,并显示该洲多个国家研究匮乏。
- 研究结果有助于制定非洲慢阻肺的循证临床指南。
研究设计与样本
- 遵循Met-Analyses and Systematic Reviews of Observational Studies指南,检索电子数据库自建库至2021年10月1日。
- 采用Newcastle-Ottawa Scale评估研究质量,并进行随机效应模型荟萃分析。
- 39项研究符合纳入标准,其中13项纳入荟萃分析。
- 方案在PROSPERO注册,注册号CRD42020210581。
主要发现
- 慢阻肺患病率按GOLD标准为2%至24%,按ATS/ERS标准为1%至17%,按MRC慢性支气管炎标准为2%至11%。
- 叙述性合成研究显示,年龄增加、喘息和哮喘是慢阻肺的一致风险因素。
- 荟萃分析显示既往结核(OR 5.98,95% CI 4.18至8.56)、吸烟(OR 2.80,95% CI 2.19至3.59)和生物质燃料使用(OR 1.52,95% CI 1.39至1.67)是显著风险因素。
- 长期氧疗(HR 4.97,95% CI 1.04至23.74)和频繁住院(≥3次/年)(HR 11.48,95% CI 1.31至100.79)是30天慢阻肺再入院的风险因素。
临床怎么用
- 在非洲人群中评估慢阻肺风险时应关注既往结核、吸烟和生物质燃料暴露。
- 对长期氧疗或每年≥3次住院的慢阻肺患者,应关注30天再入院风险。
局限性
- 仅39项研究符合纳入标准,其中仅13项进入荟萃分析,非洲多国缺乏研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This review aims to synthesise available evidence on the prevalence of chronic obstructive pulmonary disease (COPD), associated risk factors, hospitalisations and COPD readmissions in Africa. METHOD: Using the Met-Analyses and Systematic Reviews of Observational Studies guideline, electronic databases were searched from inception to 1 October 2021. The quality of studies was assessed using the Newcastle-Ottawa Scale. Evidence from retrieved articles was synthesised, and a random-effect model meta-analysis was conducted. The protocol was registered on PROSPERO. RESULTS: Thirty-nine studies met the inclusion criteria, with 13 included in the meta-analysis. The prevalence of COPD varied between the Global Initiative for Chronic Obstructive Lung Disease (2%-24%), American Thoracic Society/European Respiratory Society (1%-17%) and Medical Research Council chronic bronchitis (2%-11%) criteria, respectively. Increasing age, wheezing and asthma were consistent risk factors for COPD from studies included in the narrative synthesis. Our meta-analysis indicated that prior tuberculosis ((OR 5.98, 95% CI 4.18 to 8.56), smoking (OR 2.80, 95% CI: 2.19 to 3.59) and use of biomass fuel (OR 1.52, 95% CI: 1.39 to 1.67)) were significant risk factors for COPD. Long-term oxygen therapy (HR 4.97, 95% CI (1.04 to 23.74)) and frequent hospitalisation (≥3 per year) (HR 11.48, 95% CI (1.31 to 100.79)) were risk factors associated with 30-day COPD readmission. CONCLUSION: This study not only highlights specific risk factors for COPD risk in Africa but also demonstrates the paucity and absence of research in several countries in a continent with substantial COPD-related mortality. Our findings contribute towards the development of evidence-based clinical guidelines for COPD in Africa.PROSPERO registration numberCRD42020210581.
引用
- Njoku CM, Hurst JR, Kinsman L, et al. COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes-a systematic review and meta-analysis. Thorax. 2023. PMID: 36635039. doi:10.1136/thorax-2022-218675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。